Clinical features and prognosis of patients with myelodysplastic syndromes

Cancer Treatment Reviews

Volumn 33, Issue SUPPL. 1, 2007, Pages

  Germing, Ulrich ^a   Strupp, Corinna ^a   Giagounidis, Aristoteles ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

Author keywords

Clinical features of MDS; IPSS; MDS; Prognosis; Scoring systems; WPSS

Indexed keywords

5Q- SYNDROME; ARTICLE; BLAST CELL; BLOOD EXAMINATION; BLOOD TRANSFUSION; BONE MARROW DISEASE; BONE MARROW EXAMINATION; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMORBIDITY; CYTOPATHOLOGY; DYSPLASIA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MEDICAL DECISION MAKING; MYELODYSPLASTIC SYNDROME; ONSET AGE; PATIENT CODING; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL TIME; TREATMENT PLANNING;

EID: 35848961684     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2007.07.002     Document Type: Article

References (10)

1. Germing U., Strupp C., Kundgen A., et al. No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 89 (2004) 905-910
2. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. J Clin Oncol 17 (1999) 3835-3849
3. Bennett J.M. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72 (2000) 131-133
4. Kündgen A., Strupp C., Aivado M., et al. Myelodysplastic Syndromes under the age of 50 years. J Clin Oncol 24 (2006) 5358-5365
5. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
6. Germing U., Hildebrandt B., Pfeilstocker M., et al. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS). Leukemia 19 (2005) 2223-22231
7. Haase D, Germing U, Schanz J, et al. Comprehensive cytogenetics in MDS: correlation with morphology and delineation of new prognostic markers in 2124 patients. Blood 2007; in press.
8. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
9. Malcovati L., Germing U., Kuedgen A., et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25 (2007) 3503-3510
10. Aul C., Gattermann N., Heyll A., et al. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6 (1992) 52-59